| Product Code: ETC13167505 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Pharmacogenetic Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Pharmacogenetic Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 North America Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.8 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.10 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.11 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.12 North America Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Pharmacogenetic Testing Market Trends |
6 North America Pharmacogenetic Testing Market, 2021 - 2031 |
6.1 North America Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.1.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Array-Based Tests, 2021 - 2031 |
6.1.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Single Gene Tests, 2021 - 2031 |
6.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C19, 2021 - 2031 |
6.2.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By CYP2D6, 2021 - 2031 |
6.2.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C9 and VKORC1, 2021 - 2031 |
6.2.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By CYP1A2, 2021 - 2031 |
6.2.6 North America Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*1502, 2021 - 2031 |
6.2.7 North America Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*5701, 2021 - 2031 |
6.2.8 North America Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.3.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Nutraceuticals, 2021 - 2031 |
6.3.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Recreational Drugs, 2021 - 2031 |
6.3.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Herbal Supplements, 2021 - 2031 |
6.3.6 North America Pharmacogenetic Testing Market, Revenues & Volume, By Vitamins, 2021 - 2031 |
6.3.7 North America Pharmacogenetic Testing Market, Revenues & Volume, By Over-the-Counter Medications, 2021 - 2031 |
6.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.4.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Saliva, 2021 - 2031 |
6.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.5.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Gastroenterology, 2021 - 2031 |
6.5.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Anesthesiology, 2021 - 2031 |
6.5.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Genomics, 2021 - 2031 |
6.5.6 North America Pharmacogenetic Testing Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.5.7 North America Pharmacogenetic Testing Market, Revenues & Volume, By Immunology & Hypersensitivity, 2021 - 2031 |
6.5.8 North America Pharmacogenetic Testing Market, Revenues & Volume, By Dermatology, 2021 - 2031 |
6.5.9 North America Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Clinical Practice, 2021 - 2031 |
6.6.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Drug Development, 2021 - 2031 |
6.6.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Drug Regulation, 2021 - 2031 |
6.7 North America Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.7.3 North America Pharmacogenetic Testing Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.7.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Centres and Academic Institutes, 2021 - 2031 |
6.7.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Pharmacogenetic Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
7.3.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.4 North America Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 North America Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.6 North America Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.7 North America Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 North America Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 United States (US) Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 Canada Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Rest of North America Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Pharmacogenetic Testing Market Key Performance Indicators |
9 North America Pharmacogenetic Testing Market - Export/Import By Countries Assessment |
10 North America Pharmacogenetic Testing Market - Opportunity Assessment |
10.1 North America Pharmacogenetic Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
10.4 North America Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.5 North America Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
10.6 North America Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.7 North America Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.8 North America Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Pharmacogenetic Testing Market - Competitive Landscape |
11.1 North America Pharmacogenetic Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |